Search

Your search keyword '"Rodgers GM"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Rodgers GM" Remove constraint Author: "Rodgers GM" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
41 results on '"Rodgers GM"'

Search Results

3. The D-dimer assay.

4. Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it.

5. New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.

6. Diagnosis and treatment of cancer-related anemia.

7. How I manage patients with acquired haemophilia A.

8. Prothrombin complex concentrates in emergency bleeding disorders.

9. An inherited disorder with splenomegaly, cytopenias, and vision loss.

10. Laboratory evaluation of clopidogrel responsiveness by platelet function and genetic methods.

11. Laboratory evaluation of aspirin responsiveness.

12. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants.

13. Laboratory identification of lupus anticoagulants.

14. Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients.

15. The accuracy of activated partial thromboplastin times when drawn through a peripherally inserted central catheter.

16. Superwarfarin poisoning: a report of two cases and review of the literature.

17. A second case of prothrombin Puerto Rico I in the United States.

18. Management of cancer-associated thrombotic microangiopathy: what is the right approach?

19. Acquired amegakaryocytic thrombocytopenic purpura.

20. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.

21. Home prothrombin time monitoring: a literature analysis.

22. Parenteral iron therapy options.

23. Alterations in sensitivity to calcium and enzymatic hydrolysis of membranes from sickle cell disease and trait erythrocytes.

25. Update on selected inherited venous thrombotic disorders.

27. Excessive anticoagulation in patients with mild renal insufficiency receiving long-term therapeutic enoxaparin.

28. Utilization and outcomes of enoxaparin treatment for deep-vein thrombosis in a tertiary-care hospital.

29. Detection of occult cobalamin deficiency by magnetic resonance imaging.

30. Prolonged immunoglobulin and platelet infusion for treatment of immune thrombocytopenia.

31. Disseminated intravascular coagulation: clinical and laboratory aspects.

33. Inherited thrombotic disorders: an update.

34. Anticoagulation with anisindione in patients who are intolerant of warfarin.

35. Laboratory monitoring of warfarin therapy in Utah.

36. Laboratory and clinical aspects of inherited thrombotic disorders.

38. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells.

39. Congenital thrombotic disorders.

40. Acquired cyclic neutropenia: successful treatment with prednisone.

41. Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations.

Catalog

Books, media, physical & digital resources